Clarify some problems of pan-retinal photocoagulation for diabetic retinopathy

doi:10.13281/j.cnki.issn.1004-4469.2014.04.002

Ophthalmology in China ›› 2104, Vol. 23 ›› Issue (4): 222-225.doi: 10.13281/j.cnki.issn.1004-4469.2014.04.002

Previous Articles Next Articles

Clarify some problems of pan-retinal photocoagulation for diabetic retinopathy

TIAN Bei

Beijing Ophthalmology & Visual Sciences Key Lab.; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100703, China (Email: trtianbei@163.com)

Received:2014-05-05 Online:2014-07-25 Published:2014-07-22

Abstract

Abstract: Panretinal photocoagulation (PRP) is the only well tested and best working treatment method for diabetic retinopathy(DR). Since the number of DR patients has greatly inclined, mainland China has promoted universal standardization of PRP technology and has actively engaged in technology improvement through academic forums. This article provides opinions and suggestions on the following topics: standardization of rules, method, and timing of PRP in primary ophthalmic units, improvement of PRP technique, and full understanding the relationship between PRP and macular edema. (Ophthalmol CHN, 2014, 23: 222-225)

Key words: diabetic retinopathy, panretinal photocoagulation, macular edema

TIAN Bei. Clarify some problems of pan-retinal photocoagulation for diabetic retinopathy[J]. Ophthalmology in China, 2104, 23(4): 222-225.

[1]	Yuan Yu, Wang Jingjing. Clinical efficacy comparation of intravitreal injection of ranibizumab and macular photocoagulation for macular edema secondary to non-ischemic retinal branch vein occlusion [J]. Ophthalmology in China, 2020, 29(3): 209-213.
[2]	Liu Ying1, He Xujun2, Chen Jianbin1, Li Zhichen1, Mei Weiqun1, Zhang Huabei1, Ouyang Jian1, Qian Jiali1. A preliminary study of transcriptome in patients with diabetic retinopathy [J]. Ophthalmology in China, 2020, 29(2): 105-113.
[3]	Sun Chuan, Zhang Hongsong, Chen You, Wang Zhijun. Plasma inflammatory biomarkers in diabetic retinopathy patients with type 2 diabetes mellitus [J]. Ophthalmology in China, 2020, 29(1): 58-62.
[4]	Zhou Rui, Chen Juan, Lin Siyong. Comparison of different treatment regimens of macular edema secondary to branch retinal vein occlusion with intravitreal injection of ranibizumab [J]. Ophthalmology in China, 2020, 29(1): 63-67.
[5]	WANG Zhen-yan, CHEN Xiao-li, LI Xue-yao, ZHOU Shao-ying, SONG Yong-ji, CHEN Wei-min. Correlation between serum lipoprotein ratio and diabetic macular edema [J]. Ophthalmology in China, 2019, 28(6): 451-453.
[6]	LI Jia, ZHANG Xue-tong, WANG Ji-hong. Changes of choroidal thickness in the treatment of macular edema with anti-vascular endothelial growth factor [J]. Ophthalmology in China, 2019, 28(6): 454-457.
[7]	XIE Tian-hua, BAO Xin, SUN Chao, ZHUANG Miao, TAN Cheng-ye, YAO Yong. Comparison of the efficacy of multi-point and single-point laser in the treatment of diabetic retinopathy [J]. Ophthalmology in China, 2019, 28(5): 345-349.
[8]	LI Yi-bin. . Management tactics of diabetic retinopathy in the anti-VEGF era and the future [J]. Ophthalmology in China, 2019, 28(4): 245-248.
[9]	ZENG Hui-yang, LI Xiao-xia, LIU Qian, XIAO Yuan-yuan, HOU Si-meng. . One-year efficacy of intravitreal Conbercept injection for macular edema secondary to central retinal vein occlusion [J]. Ophthalmology in China, 2019, 28(4): 254-259.
[10]	JIAO Xuan, MO Bin, ZHOU Hai-ying. . The effect of bromfenac sodium eye drop on reducing eye pain before panretinal photocoagulation [J]. Ophthalmology in China, 2019, 28(4): 280-284.
[11]	FAN Wen-ying, LIU Ning-pu. Association between candidate gene polymorphisms and diabetic retinopathy: Meta-analysis [J]. Ophthalmology in China, 2019, 28(3): 222-228.
[12]	ZHAO Xu-li, ZHANG Di, YANG Guang, HUANG Ge. Comparison of two different regimens of intravitreal ranibizumab therapy for macular edema secondary to central retinal vein occlusion [J]. Ophthalmology in China, 2019, 28(2): 111-114.
[13]	ZHAO Ming-gui1, ZHANG Shi-hong1, SUN Yu-bo1, FANG Ke-shuang1, YOU Qi-sheng2. Vitrectomy combined with different dosing regimen of ranibizumab for treatment of proliferative diabetic retinopathy [J]. Ophthalmology in China, 2019, 28(2): 115-119.
[14]	JI Shuai-fei, NING Xiao-na, ZHANG Jie. Neutrophil to lymphocyte ratio for diagnosis of diabetic retinopathy: a Meta-analysis [J]. Ophthalmology in China, 2018, 27(6): 442-446.
[15]	WANG Juan1, CHEN Shu-juan1, DONG Fang-tian2, GONG Di2, TANG Yi1, JIN Meng1, ZHAO Lei1, CHANG Hai-lian3, LIU Feng-tong3, ZHANG Jian3, REN An-na3, ZHANG Fan3 . Comparison of computer automated screening system with ophthalmologist for grading of diabetic retinopathy [J]. Ophthalmology in China, 2018, 27(4): 254-257.

Clarify some problems of pan-retinal photocoagulation for diabetic retinopathy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments